Dr. Paul Geeleher focuses on developing and validating computational methods/approaches in genomics and transnational medicine. We are interested in problems such as the contribution of inherited genetic variation to disease risk and drug response in cancer, characterization of new pharmacogenomic biomarkers and drug repositioning. We are a primarily computational lab, with a major focus on methods development, but also have a strong wet-bench component. Our work is grounded in the objective to improve patient outcome.
The Geeleher Lab is associated with the Department of Computational Biology, the Graduate School of Biomedical Sciences and the Comprehensive Cancer Center at St. Jude Children’s Research Hospital in Memphis Tennessee. St. Jude has recently been ranked the #1 Pediatric Cancer Hospital.